A method for preparing bayberry anthocyanin chewable tablets
High-purity myricetin was extracted from bayberries using green solvents and macroporous resin technology. Combined with maltodextrin and lutein esters, chewable tablets were prepared, solving the problems of toxic solvent residues and low purity in the extraction process of myricetin. This enabled the development of high-value-added products and the application of portable functional foods.
Patent Information
- Application Number
- CN202611411230.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-11
- Publication Date
- 2026-11-17
AI Technical Summary
The existing technology uses toxic organic solvents in the extraction process of bayberry anthocyanins, resulting in residues in the product that are harmful to human health. In addition, the purity of the extract is low, which limits the development and application of high value-added products.
High-purity myricetin was prepared by using green solvents ethanol and citric acid as extraction agents, combined with macroporous resin adsorption and ethanol elution technology. The myricetin was then mixed with maltodextrin and pressed into chewable tablets, with lutein ester added to enhance its antioxidant effect.
The efficient and stable extraction and purification of bayberry anthocyanins has been achieved, improving the purity and color of the product. The chewable tablets are portable and have a good taste, expanding their application in the field of functional foods, especially showing significant effects in eye-protecting functional foods.
Smart Images

Figure CN123100818A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of natural product extraction and food processing technology, specifically relating to a method for extracting and purifying anthocyanins from bayberries, and a method for preparing bayberry anthocyanins into chewable tablet products. Background Technology
[0002] The Chinese bayberry (Myrica rubra) is a perennial evergreen small tree or shrub belonging to the Myricaceae family and the Myrica genus. my country is a major producer of Chinese bayberries. The fruit is brightly colored, sweet and sour, and has a rich aroma. Chinese bayberry fruit is rich in anthocyanins, the main water-soluble natural pigments that give the fruit its purplish-red color, and are also important bioactive components. Studies have shown that Chinese bayberry anthocyanins possess various biological activities, including antioxidant, anti-inflammatory, antibacterial, and lipid-lowering effects, and have significant application potential in functional foods and health products. Currently, the main processed products of bayberry fruit in China include primary processed products such as quick-frozen fresh fruit, jam, juice, concentrated juice, and fruit wine, as well as baked and frozen snack foods such as dried fruit, bayberry crisps, and bayberry ice cream. However, high-value-added products such as anthocyanin chewable tablets, powders, and oral liquids with bayberry anthocyanins as the core are not common in the domestic market. Considering that my country has a huge bayberry production, a short harvesting period, and is not easy to store for long periods, developing high-value-added bayberry products can promote the transformation and upgrading of the bayberry industry, increase farmers' income, and promote the branding of local specialty agricultural products.
[0003] Compared to powders and oral liquids, anthocyanin chewable tablets offer better anthocyanin stability. Furthermore, chewable tablets are more portable, convenient to use, and have a better taste, making them an important carrier for functional foods and a preferred dosage form for the industrialization of anthocyanins. Currently, anthocyanin chewable tablets sold in the domestic market mainly come from blueberries or black goji berries and other raw materials. There are currently no chewable tablet products on the market with bayberry anthocyanins as the main active ingredient. Therefore, developing bayberry anthocyanin chewable tablets has significant innovative value and can promote the development of high-value-added bayberry products.
[0004] Currently, methods for extracting anthocyanin compounds from plants include organic solvent extraction, ultrasound-assisted extraction, and enzymatic extraction. Numerous studies have been conducted on myrica rubra anthocyanins in this field. Patent 1 (CN200510111686.2, Patent Title: Method for Preparing Myrica Rubra Anthocyanin Extract, Myrica Rubra Anthocyanin Extract and Its Uses) mentions using hydrochloric acid to adjust the acidity of the macroporous resin eluent. Patent 2 (CN202310839364.8, Patent Title: Application of Myrica Rubra Fruit Anthocyanin Extract in the Preparation of Drugs for Treating Behavioral Disorders) uses formic acid as the acidity regulator and methanol as the eluent in the preparation of crude myrica rubra anthocyanin extract. Most of these methods involve the use of toxic organic reagents such as hydrochloric acid, formic acid, methanol, and acetone. The residues of these toxic organic reagents in anthocyanin products pose a significant health risk, thus limiting the development of high-value-added anthocyanin products. How to prepare myrica rubra anthocyanin extract using green extraction and purification technologies remains a key problem that needs to be solved. Furthermore, in existing technologies, crude extracts obtained through organic solvent extraction typically have low purity and contain impurities such as sugars and saponins, thus limiting their high-value applications. Given that there are currently no domestic literature reports on the development of bayberry anthocyanin chewable tablets, developing bayberry anthocyanin chewable tablets has significant innovative potential and market prospects. Summary of the Invention
[0005] The purpose of this invention is to overcome the shortcomings of existing technologies, provide a green extraction and purification process for bayberry anthocyanins, and further explore a chewable tablet with the purified product as the core active ingredient and its preparation method, thereby realizing the high-value utilization of bayberry resources.
[0006] The beneficial effects of this invention are as follows:
[0007] (1) This invention provides an extraction process for anthocyanins from bayberry, using a green and non-toxic solvent that can efficiently and stably extract and purify anthocyanins from bayberry.
[0008] (2) This invention screened out macroporous resins suitable for the separation and purification of anthocyanins from bayberries, established the optimal adsorption dynamics and elution process parameters, significantly improved the anthocyanin content and purity in the product, and is beneficial to the subsequent development of refined products.
[0009] (3) The present invention uses crude extract of bayberry anthocyanin to increase the natural purple-red color of chewable tablets and uses purified bayberry anthocyanin to increase the anthocyanin content in tablets, which can both ensure the anthocyanin content in tablets and make tablets closer to the natural color of bayberries.
[0010] (4) This invention innovatively develops the purified anthocyanin of bayberry into chewable tablets, which effectively solves the problems of poor taste, poor color and poor absorption. The product is easy to carry and convenient to eat, and has a sweet and sour taste, which greatly expands the application of bayberry in the field of portable functional food.
[0011] (5) In the formulation design of the bayberry anthocyanin chewable tablets, the present invention not only makes the anthocyanin content in each tablet reach more than 5mg, but also adds lutein ester and makes its content also reach more than 5mg. By combining water-soluble anthocyanin and fat-soluble lutein ester in the chewable tablets, the effects of the two antioxidants can be fully utilized, especially in the field of eye-protecting functional foods with great application prospects.
[0012] To achieve the above objectives, the present invention employs the following specific steps:
[0013] Step 1: Using fresh or frozen bayberry fruit as raw material, and ethanol, purified water, and citric acid as extraction solvents, prepare bayberry anthocyanin extract;
[0014] Step 2: Combine the extracts and prepare concentrated myricetin solution under reduced pressure;
[0015] Step 3: Mix the anthocyanin concentrate from Step 2 with maltodextrin in a certain proportion, and dry with hot air to obtain crude extract of bayberry anthocyanins.
[0016] Step 4: The anthocyanin concentrate obtained in Step 2 is loaded onto a macroporous resin column at an appropriate flow rate, eluted with ethanol solution, the eluent is collected, concentrated under reduced pressure and freeze-dried to obtain the purified bayberry anthocyanin.
[0017] Step 5: Mix the purified and crude extracts of bayberry anthocyanins and other excipients according to the formula and compress them into tablets to obtain bayberry anthocyanin chewable tablets.
[0018] The preparation method of the myricetin extract in step one is as follows:
[0019] Using fresh or frozen bayberry fruit as raw material, the bayberry fruit is first crushed and made into a homogenate. Ethanol and citric acid are used as extraction solvents. 50-80% ethanol is added to the fruit homogenate at a volume ratio of 1:6 to 1:10. The pH value is adjusted to 2-3 using citric acid. After stirring for 30-60 minutes, the mixture is soaked at a temperature of 25-45℃ for 24-36 hours. After filtering the extract, the residue is extracted a second time.
[0020] The preparation method of the anthocyanin concentrate in step two is as follows:
[0021] The extracts were combined and concentrated to 1 / 10 to 1 / 15 of their original volume under a temperature of 50-65℃ and a vacuum of -0.08 to -0.1 MPa to obtain concentrated myricetin solution.
[0022] The preparation method of the crude extract of bayberry anthocyanins described in step three is as follows:
[0023] Maltodextrin was added to the concentrated myricetin solution of bayberry, and the amount added was 0.1~0.2 g maltodextrin / mL of concentrated solution. The mixture was dried by hot air at 35~50℃ to obtain dried myricetin-maltodextrin product. The dried product was pulverized and passed through an 80-mesh sieve to obtain crude myricetin extract.
[0024] The preparation method of the purified myricetin in step four is as follows:
[0025] The anthocyanin concentrate obtained in step two was packed into a macroporous resin column using a wet method, with a sample loading volume of 1 / 10 to 1 / 15 of the resin volume. Elution was first performed with 0.05 to 0.1% citric acidified water for 6 to 10 column volumes, followed by elution with 35 to 65% ethanol solution. The eluent was collected and concentrated under reduced pressure at 50 to 65°C and a vacuum of -0.08 to -0.1 MPa to 1 / 10 to 1 / 15 of its original volume. Then, it was freeze-dried under vacuum to obtain the purified myricetin lyophilized powder.
[0026] The tablet compression method for the bayberry anthocyanin chewable tablets described in step five is as follows:
[0027] After passing through an 80-mesh sieve, the freeze-dried powder of bayberry anthocyanins, crude bayberry extract, sweetener, acidulant, filler, and lubricant are mixed evenly according to the formula. The tablets are then compressed using a direct compression method with a mold having an inner diameter of 20 mm on a tableting machine. The tablet weight is controlled to be 1.0 g / tablet. After compression and demolding, the bayberry anthocyanin chewable tablets are obtained.
[0028] The citric acid used in steps one and four is a food-grade additive.
[0029] The macroporous resin used in step four is Amberlite XAD-7 type macroporous resin;
[0030] In step four, the total anthocyanin content in the purified bayberry anthocyanin was determined by pH differential method and converted into purity. The purity range of bayberry anthocyanin was found to be 16%~20%.
[0031] The chewable tablet formulation in step five consists of the following components by mass fraction: 2-3 parts purified myricetin, 25-35 parts crude myricetin extract, 5-10 parts lutein ester, 15-25 parts maltodextrin, 25-35% erythritol, 5-15 parts citric acid, 0.1-0.2 parts magnesium stearate, and 0.1-0.2 parts vitamin C. Attached Figure Description
[0032] Figure 1 Roadmap for the preparation of freeze-dried powder of total anthocyanins from bayberry.
[0033] Figure 2 Flowchart of the preparation process for bayberry anthocyanin chewable tablets. Detailed Implementation
[0034] The present invention will be further described below by way of specific embodiments.
[0035] Example 1:
[0036] Step 1: Take 200 g of frozen bayberry fruit. First, crush the bayberry fruit and make it into a homogenate. Use ethanol and citric acid as extraction solvents. Add 70% ethanol to the fruit homogenate at a volume ratio of 1:10. Adjust the pH value to 3 with citric acid. Stir for 30 minutes and soak at 40℃ for 24 hours. After filtering the extract, extract the residue twice more.
[0037] Step 2: Combine the extracts and concentrate the myrica extract to 1 / 12 of its original volume under the conditions of 60℃ and -0.1 MPa vacuum, to obtain approximately 160 mL of concentrated myrica extract.
[0038] Step 3: Take 80 mL of concentrated bayberry anthocyanin solution, add 15 g of maltodextrin to it, and dry the mixture with hot air at 45℃ to obtain dried bayberry anthocyanin-maltodextrin; pulverize the dried product and pass it through an 80-mesh sieve to obtain 21 g of crude bayberry anthocyanin extract.
[0039] Step 4: 80 mL of the concentrated myricetin solution from Step 2 was loaded into Amberlite XAD-7 macroporous resin using a wet loading method. The sample volume was 1 / 8 of the resin volume. First, elution was performed with 0.1% citric acidified water for 8 column volumes. Then, elution was performed with 65% ethanol solution. The eluent was collected and concentrated under reduced pressure at 60℃ and -0.1 MPa to reduce the eluent to 1 / 10 of its original volume. Finally, it was freeze-dried under vacuum to obtain 453 mg of purified myricetin lyophilized powder.
[0040] Step 5: After passing the freeze-dried powder of bayberry anthocyanins, crude extract of bayberry anthocyanins, sweetener, acidulant, filler, and lubricant through an 80-mesh sieve, mix them evenly according to the formula. Use the direct tableting method and select a mold with an inner diameter of 20 mm on a tableting machine to compress the tablets, controlling the tablet weight to be 1.0 g / tablet. After tableting and demolding, the bayberry anthocyanin chewable tablets are obtained.
[0041] In step four, the total anthocyanin content in the purified bayberry anthocyanin was determined using the pH difference method and converted into purity, with the bayberry anthocyanin purity measured to be 18.5%.
[0042] The chewable tablet formulation in step five consists of the following components by mass fraction: 3 parts purified myricetin, 30 parts crude myricetin extract, 10 parts lutein ester, 25 parts maltodextrin, 25 parts erythritol, 10 parts citric acid, 0.1 parts magnesium stearate, and 0.1 parts vitamin C.
[0043] Several compressed brownish-red bayberry anthocyanin chewable tablets were crushed using a pulverizer, passed through an 80-mesh sieve, and 0.5 g of powder was weighed and dissolved in an acidified ethanol solution. After filtering the insoluble matter with filter paper, the anthocyanin content of the filtrate was detected by pH differential method. The anthocyanin content in the bayberry anthocyanin chewable tablets was finally measured to be 5.38 mg / g.
[0044] Example 2:
[0045] Step 1: Take 100 g of frozen bayberry fruit. First, crush the bayberry fruit and make it into a homogenate. Use ethanol and citric acid as extraction solvents. Add 60% ethanol to the fruit homogenate at a volume ratio of 1:6. Adjust the pH value to 3 with citric acid. Stir for 30 minutes and soak at 25℃ for 24 hours. After filtering the extract, extract the residue twice more.
[0046] Step 2: Combine the extracts and concentrate the myrica extract to 1 / 10 of its original volume under the conditions of 55℃ and -0.1 MPa vacuum, to obtain 100 mL of concentrated myrica extract.
[0047] Step 3: Take 50 mL of concentrated bayberry anthocyanin solution and add 8 g of maltodextrin to it. Dry the mixture at 40°C with hot air to obtain dried bayberry anthocyanin-maltodextrin. Crush the dried product and pass it through an 80-mesh sieve to obtain 10.6 g of crude bayberry anthocyanin extract.
[0048] Step 4: 50 mL of the anthocyanin concentrate obtained in Step 2 was loaded into Amberlite XAD-7 macroporous resin using a wet loading method. The sample volume was 1 / 8 of the resin volume. First, it was eluted with 0.05% citric acid water for 10 column volumes, and then eluted with 60% ethanol solution. The eluent was collected and concentrated under reduced pressure at 55℃ and -0.1 MPa to reduce the eluent to 1 / 10 of its original volume. Then, it was freeze-dried under vacuum to obtain 197 mg of the purified myricetin lyophilized powder.
[0049] The freeze-dried powder of bayberry anthocyanins, crude extract of bayberry anthocyanins, sweetener, acidulant, filler, and lubricant are passed through an 80-mesh sieve and mixed evenly according to the formula. The tablets are then compressed using a direct compression method with a mold having an inner diameter of 20 mm on a tableting machine. The tablet weight is controlled to be 1.0 g / tablet. After compression and demolding, the bayberry anthocyanin chewable tablets are obtained.
[0050] In step four, the total anthocyanin content in the purified bayberry anthocyanin was determined using the pH difference method and converted into purity. The purity range of bayberry anthocyanins was found to be 19.7%.
[0051] The chewable tablet formulation in step five consists of the following components by mass fraction: 3 parts purified myricetin, 35 parts crude myricetin extract, 8 parts lutein ester, 20 parts maltodextrin, 30 parts erythritol, 8 parts citric acid, 0.1 parts magnesium stearate, and 0.1 parts vitamin C.
[0052] Several pressed light pink bayberry anthocyanin chewable tablets were crushed using a pulverizer, passed through an 80-mesh sieve, and 0.5 g of powder was weighed and dissolved in an acidified ethanol solution. After filtering the insoluble matter with filter paper, the anthocyanin content of the filtrate was detected using the pH difference method. The final anthocyanin content in the bayberry anthocyanin chewable tablets was 5.67 mg / g.
[0053] The above embodiments are only used to illustrate the technical solutions of the present invention and do not constitute a limitation on the scope of protection of the present invention. Equivalent changes or reasonable substitutions made by those skilled in the art to related technical solutions without departing from the technical concept and substance of the present invention should be considered to fall within the scope of protection of the present invention.
Claims
1. A method for preparing bayberry anthocyanin chewable tablets, characterized in that, Includes the following steps: Step 1: Preparation of anthocyanin extract: Using fresh or frozen bayberry fruit as raw material, the bayberry fruit is first crushed and homogenized. Ethanol and citric acid are used as extraction solvents. Ethanol with a concentration of 50% to 80% is added to the fruit homogenate at a volume ratio of 1:6 to 1:
10. The pH value is adjusted to 2 to 3 using citric acid. After stirring for 30 to 60 minutes, the mixture is soaked at a temperature of 25 to 45°C for 24 to 36 hours. After filtering the extract, the residue is extracted twice more. Step 2, Preparation of concentrated solution: Combine the extracts and concentrate the myrica rubra anthocyanin extract to 1 / 10 to 1 / 15 of its original volume under the conditions of temperature 50~65℃ and vacuum degree -0.08~-0.1MPa to obtain myrica rubra anthocyanin concentrated solution; Step 3: Preparation of crude extract: Add maltodextrin to the concentrated myricetin solution, with an addition amount of 0.1~0.2g maltodextrin / mL concentrate. Dry the mixture with hot air at 35~50℃ to obtain dried myricetin-maltodextrin product. Crush the dried product and pass it through an 80-mesh sieve to obtain crude myricetin extract. Step 4: Preparation of purified product: The anthocyanin concentrate obtained in Step 2 is packed into a macroporous resin column using a wet method. The sample loading volume is 1 / 8 to 1 / 10 of the resin volume. First, it is eluted with 0.05 to 1% citric acidified water for 6 to 10 column volumes. Then, it is eluted with 35 to 65% ethanol solution. The eluent is collected and concentrated under reduced pressure at a temperature of 50 to 65℃ and a vacuum degree of -0.08 to -0.1 MPa to reduce the eluent to 1 / 8 to 1 / 10 of its original volume. Then, it is freeze-dried under vacuum to obtain the lyophilized powder of the purified myricetin. Step 5: Tableting the chewable tablets: After passing the freeze-dried powder of purified myricetin, crude myricetin extract, sweetener, acidulant, filler, and lubricant through an 80-mesh sieve, mix them evenly according to the formula and compress them to obtain the myricetin chewable tablets.
2. The method for preparing a myricetin chewable tablet according to claim 1, characterized in that, The citric acid used in steps one and four is a food-grade additive.
3. The method for preparing a myricetin chewable tablet according to claim 1, characterized in that, The macroporous resin used in step four is Amberlite XAD-7 type macroporous resin.
4. The method for preparing a myricetin chewable tablet according to claim 1, characterized in that, In step four, the total anthocyanin content in the purified bayberry anthocyanin was determined by pH differential method and converted into purity. The purity range of bayberry anthocyanin was found to be 16% to 20%.
5. The method for preparing a myricetin chewable tablet according to claim 1, characterized in that, The chewable tablet formulation in step five consists of the following components by mass fraction: 2-3 parts of purified lyophilized myricetin powder, 25-35 parts of crude myricetin extract, 5-10 parts of lutein ester, 15-25 parts of maltodextrin, 25-35 parts of erythritol, 5-15 parts of citric acid, 0.1-0.2 parts of magnesium stearate, and 0.1-0.2 parts of vitamin C.
Citation Information
Patent Citations
Application of Myrica rubra Fruit Anthocyanin Extract in the Preparation of a Drug for Treating Behavioral Disorders
CN117100776B
Bayberry cyanidin extract
CN1986539A
